Ventricular Tachycardia – The Most Serious Warning from the Heart

If You Say, "This Palpitation Feels Different from the Others"

Some palpitations are bothersome yet harmless. Others create a dizzying, breathtaking, and occasionally consciousness-clouding condition that originates deep within the heart. Ventricular tachycardia — VT — is a rhythm disorder falling into the second group that must always be taken seriously.

VT manifests with rapid and abnormal electrical activity beginning in the ventricles, which are the lower chambers of the heart. This is its fundamental difference from atrial-origin tachycardias: the signal this time originates directly from the heart’s pumping center, namely the ventricles themselves. This distinction profoundly alters both the severity of the condition and the treatment approach.

VT does not present the same way in every patient. While some patients experience only palpitations and dizziness, others may encounter sudden loss of consciousness or cardiac arrest. This wide spectrum clearly demonstrates why VT must be handled with such careful consideration.

What is Ventricular Tachycardia?

In a normal heart, the electrical signal starts in the sinus node, is transmitted via the AV node to the bundle of His, and spreads from there to the ventricles through the right and left bundle branches. This pathway is fast, regular, and coordinated; every electrical signal triggers a contraction, and blood is pumped to the body.

In VT, this order is disrupted. An abnormal focus or closed electrical circuit located inside or within the wall of the ventricles begins to fire uncontrollably. The heart rate rises to between 100 and 250 beats per minute — and in some cases even higher. At this rate, the heart cannot fill and empty adequately; blood pressure drops, and the brain and organs fail to receive sufficient blood.

Apical Ventricular Tachycardia Ablation from the Endocardial Left Ventricle

How Long Does VT - Ventricular Tachycardia Last? When Does the Danger Begin?

VT is divided into two main groups based on its duration and whether it terminates spontaneously.

Non-sustained VT: These are VT episodes lasting less than thirty seconds and ending spontaneously. They may be asymptomatic or cause only a brief sensation of palpitations. They can be discovered incidentally on Holter monitoring. If there is no structural heart disease, the prognosis is usually benign; however, it must be evaluated carefully if underlying heart disease is present.

Sustained VT: These are VT episodes lasting longer than thirty seconds or failing to terminate spontaneously. They carry a risk of hemodynamic compromise, loss of consciousness, or cardiac arrest and definitely require intervention. This group is always a medical condition requiring urgent evaluation.

The Foundation of VT: Ischemic or Nonischemic?

The most fundamental way to understand ventricular tachycardia is to classify it according to the underlying heart disease. This distinction is not merely academic; it is of clinical significance that directly determines the treatment strategy, prognostic assessment, and long-term management.

Ischemic VT — The Long Shadow of a Past Infarction

How Does It Develop?

Ischemic VT is the most frequent and most dangerous type of VT developing on the background of a past myocardial infarction — heart attack. Muscle cells deprived of oxygen during a heart attack die and are replaced by scar tissue. This scar tissue cannot conduct electricity; however, together with the surviving tissues around it, it forms slow conduction channels. These very channels are the building blocks of the VT circuit.

The electrical signal passes through these slow channels, spreads to the surrounding viable tissue, and returns to the channel, forming a closed loop. Once established, this circuit feeds itself, and the ventricles continue to be stimulated rapidly. This mechanism is called scar-related macro-reentry, and this mechanism lies behind the vast majority of ischemic VTs.

Who Does It Affect?

The risk is markedly increased in patients who have had a heart attack, especially those with reduced left ventricular pumping power — ejection fraction. The larger and older the infarction, the more widespread the scar tissue, which paves the way for more complex VT circuits. Ischemic VT can mostly appear months or years after the infarction.

What is the Clinical Presentation?

Ischemic VT spans a wide spectrum, ranging from forms that are hemodynamically well-tolerated to those that run a highly dramatic course. While some patients can remain upright with palpitations for a long time, others may develop loss of consciousness and cardiac arrest within minutes. In patients with a low ejection fraction, the hemodynamic tolerance of VT is generally poor.

How is Treatment Planned?

Ischemic VT treatment is multi-layered. First and foremost, the treatment of the underlying ischemia — coronary artery disease — is essential; if active coronary disease is present, revascularization must be achieved. Additionally, there are three main treatment pillars.

ICD — Implantable Cardioverter Defibrillator: In patients with an ejection fraction below a certain threshold or those experiencing sustained VT, ICD implantation is the most powerful treatment option to prevent sudden death. When VT develops, the ICD automatically detects it and corrects the rhythm with an electrical shock if necessary. It is a life-saving device, but it does not prevent VT; it only intervenes when VT develops.

Antiarrhythmic Drugs: Various antiarrhythmic drugs, notably amiodarone, can reduce the frequency of VT episodes. They are used especially to reduce the burden of ICD shocks. The side effect profile must be taken into account during long-term use.

Catheter Ablation: Ischemic VT ablation targets the slow conduction channels inside and around the scar tissue. Using three-dimensional mapping systems, an exact map of the scar is created, critical channels of the VT circuit are identified, and these points are deactivated via ablation. Ablation significantly reduces VT episodes and ICD shocks. However, success rates vary depending on the extent of the scar and left ventricular function; complete or significant reduction is usually achieved in 60 to 80 percent of cases. Ischemic VT ablation is a technically challenging procedure and should be performed in experienced centers.

Ventricular Tachycardia Ablation from the Posteroseptal Region of the Left Ventricle

Nonischemic VT — Different Backgrounds, Different Presentations

General Framework

Nonischemic VT encompasses ventricular tachycardia developing without coronary artery disease or a past heart attack. The type of underlying heart disease can vary widely; conditions such as dilated cardiomyopathy, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy — ARVC —, myocarditis, and sarcoidosis are among the main causes of this group. Furthermore, nonischemic VT can also develop in a heart that appears structurally completely normal; this group is called idiopathic VT.

Dilated Cardiomyopathy-Induced VT

In dilated cardiomyopathy, which proceeds with weakening and enlargement of the heart muscle, scar tissue and areas of fibrosis are distributed diffusely. The VT mechanism is similar to ischemic VT, but the distribution of the scar is more heterogeneous and the circuit pathways are more complex. In these patients, VT presenting with a left bundle branch block appearance is frequently encountered, and the left ventricular outflow tract or the mitral annular region are among frequent source points. ICD implantation and ablation are important treatment options in this group as well.

Arrhythmogenic Right Ventricular Cardiomyopathy — ARVC

ARVC is a genetically transmitted disease where the right ventricular muscle tissue is replaced by fat and fibrous tissue. It is of particular importance because it can lead to sudden cardiac death in young and active individuals — especially athletes. VT is generally in the left bundle branch block appearance; meaning the signal originates from the right ventricle. Epsilon wave and right precordial T wave inversion on the ECG are among the findings pointing to the diagnosis. Avoiding high-intensity exercise, ICD implantation, and ablation when necessary form the basis of treatment in these patients.

Myocarditis and Sarcoidosis-Induced VT

Damage to the heart muscle through inflammation — myocarditis — or granuloma formation — sarcoidosis — also creates a significant background for VT. In these patients, the VT circuit develops around inflammatory scar foci. Sarcoidosis-induced VT can run a particularly treatment-resistant course and may require multiple ablation sessions. Controlling the underlying disease with immunosuppressive therapy is an integral part of VT management.

Idiopathic VT — Signals Coming from a Structurally Normal Heart

VT can also develop in a heart that appears structurally completely normal. This group is especially important because patients are usually young and seemingly healthy. The most frequent sources of idiopathic VT are specific anatomical points.

Right ventricular outflow tract — RVOT — VT: This is the most frequently seen type of idiopathic VT. The source point is in the right ventricular outflow tract below the pulmonary valve. It can be triggered by exercise or stress; it manifests with palpitations, dizziness, and rarely fainting. A left bundle branch block and inferior axis appearance on the ECG is characteristic. Ablation is extremely successful in this type; lasting success is achieved at a rate of 85 to 95 percent.

Left ventricular outflow tract — LVOT — VT: This is a type originating from the left side with mechanisms similar to RVOT VT, but localized differently. It can originate from the subaortic region, the area between the aortic valve cusps, or near the mitral valve annulus. Ablation is an effective option for these cases as well.

Papillary muscle-induced VT: This type, originating from the mitral valve papillary muscles, presents a technically challenging ablation target due to its localization. Success rates are slightly lower compared to other idiopathic types.

Ventricular Tachycardia Ablation from the Mid-Septal Region of the Left Ventricle

Fascicular VT — A Special Group, A Special Treatment

What is it?

Fascicular VT is a specific type of VT originating from the fascicles — branch fibers — within the conduction system of the left ventricle. It is not associated with ischemic or structural heart disease; it occurs in a completely healthy heart, usually in young men. Therefore, it is also known as idiopathic left ventricle VT or Belhassen VT, named after the researcher who discovered it.

What is the Electrical Mechanism?

The vast majority of fascicular VT originates from the left posterior fascicle of the left ventricle; less frequently, it can be located in the left anterior fascicle or septal branches. The mechanism is based on reentry; however, this circuit is located within the conduction system tissue, not the myocardium. This specific tissue is sensitive to verapamil — a calcium channel blocker — which is why fascicular VT is also referred to as “verapamil-sensitive VT.”

How Does It Look on an ECG?

The ECG appearance of fascicular VT is extremely characteristic and easily recognized by an experienced eye. The combination of right bundle branch block appearance and left superior axis is the classic presentation. The QRS duration is relatively short — a narrower QRS compared to other VT types — and this feature helps distinguish fascicular VT from other wide-complex tachycardias.

Who Gets It?

Fascicular VT is typically encountered in young men between the ages of 20 and 40. There is no structural heart disease; it can be triggered by exercise but can also occur at rest. Palpitations, dizziness, and mild shortness of breath are the most common symptoms. The risk of sudden death is extremely low compared to VT types developing on the background of structural heart disease.

How Is It Treated?

Two options stand out in the treatment of fascicular VT.

Verapamil: Administered intravenously during an initial attack, verapamil mostly terminates VT rapidly. Long-term oral verapamil use can suppress attacks; however, attacks may resume when the medication is stopped.

Catheter Ablation — The Preferred Permanent Treatment: Fascicular VT ablation targets the critical point of the circuit within the conduction system. Ablation is applied near the left posterior fascicle, at the point where slow conduction potentials are recorded. Although this procedure requires technical precision, extremely high success rates between 90 and 95 percent are achieved in experienced centers. Following successful ablation, the vast majority of patients can lead medication-free and palpitation-free lives.

What Are the Common Symptoms of VT?

Symptoms of ventricular tachycardia vary greatly depending on both the underlying heart disease and the VT rate.

Sudden-onset rapid palpitations are the most commonly reported complaint. Dizziness and a feeling of lightheadedness become pronounced especially when hemodynamic deterioration occurs. Shortness of breath and a feeling of tightness or pressure in the chest may accompany. Sweating and paleness reflect the body’s reaction to dropping blood pressure. Fainting or the sensation of darkening vision preceding fainting is a serious warning sign. At the most severe end are loss of consciousness and cardiac arrest.

In some patients — particularly in cases of non-sustained VT — the condition may be accidentally noticed on a Holter monitor without any symptoms at all.

How Is Ventricular Tachycardia Diagnosed?

ECG: It is the first and most critical tool in diagnosing VT. An ECG taken during VT shows a rapid rhythm with wide QRS complexes — usually over 120 milliseconds. The QRS morphology provides important clues for localizing both the VT type and the source point.

Holter monitoring: In cases of intermittent or non-sustained VT, a 24–48 hour Holter recording is valuable to document the frequency, duration, and character of attacks. Long-term recording devices can be used for infrequent attacks.

Echocardiography: Essential for evaluating left ventricular functions, ejection fraction, wall motion abnormalities, and structural heart disease. Since ejection fraction is a decisive parameter in the ICD implantation decision, echocardiography must be performed in all VT patients.

Cardiac MRI: Shows scar tissue and fibrosis distribution in extreme detail. It is of critical importance especially in nonischemic cardiomyopathies, suspected ARVC, and the evaluation of myocarditis or sarcoidosis. It can also be used to pre-map scar distribution in ablation planning.

Electrophysiological study and three-dimensional mapping: A comprehensive evaluation is performed in the electrophysiology laboratory for patients scheduled for VT ablation. The three-dimensional mapping system creates an exact anatomical and electrical map of the ventricle. Scar areas, slow conduction channels, and critical circuit points are detected with millimetric precision. This mapping both reinforces the diagnosis and determines the ablation strategy.

Coronary angiography: Especially in newly diagnosed patients or those with risk factors, coronary anatomy should be evaluated to clarify whether there is an ischemic background.

What to Do in a Ventricular Tachycardia Emergency?

Intervention during a VT attack is shaped according to the patient’s consciousness and hemodynamic status.

VT with a pulse and conscious: An attempt is made to correct the rhythm with intravenous antiarrhythmic medication — amiodarone, lidocaine. Electrical cardioversion is applied if there is hemodynamic deterioration.

VT with a pulse but hemodynamically worsening: Emergency synchronized electrical cardioversion is applied.

Pulseless VT — cardiac arrest: CPR is initiated and a shock is delivered with a defibrillator. This situation is a life-threatening emergency; 112 should be called immediately.

ICD — The Life-Saving Device

ICD implantation is the most effective treatment method for preventing sudden death in patients at risk for ventricular tachycardia and ventricular fibrillation. The device continuously monitors the heart rhythm; when a dangerous rhythm disorder is detected, it first attempts to correct the rhythm with rapid pacing, and if unsuccessful, automatically delivers an electrical shock.

ICD implantation is strongly recommended by guidelines in patients whose ejection fraction is below a certain threshold, patients who have suffered sustained VT or ventricular fibrillation, and special groups carrying a high risk of sudden death.

An ICD does not restrict quality of life; patients can largely continue their normal daily lives. However, in patients experiencing frequent shocks — a condition called ICD storm — the shock burden can be significantly reduced with ablation.

Catheter Ablation — How Effective Is It in VT?

VT ablation has developed dramatically over the past decade. Three-dimensional mapping, high-intensity focused ultrasound, contact force-sensing catheters, and epicardial ablation techniques are the cornerstones of progress in this field.

Idiopathic VT ablation — RVOT, LVOT, fascicular — results in extremely high success rates and permanent success is usually achieved in a single session. This group is the type of VT where ablation yields the most satisfying results.

Ischemic VT ablation yields variable results depending on the extent of the scar, the number of VT circuits, and left ventricular function. Successful ablation significantly reduces VT attacks and ICD shocks; however, recurrence is possible in the long term, and ICD protection is maintained in most patients.

VT ablation due to nonischemic cardiomyopathy can be particularly technically challenging due to the mid-myocardial or epicardial distribution of the scar. In these cases, epicardial — outer surface — ablation may be required via both the endocardial — inner surface — and pericardial space.

In Which Situations Is Emergency Presentation Essential?

In any of the following situations, 112 should be called without delay or you should go to the nearest emergency department:

Sudden loss of consciousness or near-fainting sensation, palpitations accompanied by severe shortness of breath, intense pain or pressure feeling in the chest, rapid palpitations accompanied by paleness and excessive sweating, and feeling a shock in patients with an ICD device are at the forefront of these emergency situations. An ICD shock alone is a reason to present to the emergency department; the shock is an indicator that the body has perceived a danger.

Lifestyle and Long-Term Follow-up

Regular cardiology follow-up is mandatory for patients diagnosed with VT. Optimal treatment of the underlying heart disease — coronary disease, heart failure, cardiomyopathy — is an integral part of VT management. Triggering factors — electrolyte disturbances, sleep apnea, excessive stress — must be brought under control. Left ventricular functions are monitored via annual echocardiography. Device checks are performed at regular intervals in patients with an ICD.

Regarding exercise, each patient should be evaluated individually. Return to exercise is possible after ablation in idiopathic forms such as fascicular VT or RVOT VT. In VTs on the background of structural heart disease, individual exercise restrictions determined by the cardiologist can be applied.

Conclusion

Ventricular tachycardia is a highly heterogeneous rhythm disorder in terms of its origin, mechanism, and underlying background. There is a wide spectrum ranging from forms seen in young and healthy individuals that can be permanently treated with ablation, such as fascicular VT, to complex conditions developing on the background of ischemic cardiomyopathy where ICD and ablation are used together.

Each type of VT requires a specific evaluation and treatment plan. The common point is this: accurate diagnosis, comprehensive evaluation by an experienced electrophysiologist, and individualized treatment significantly improve both quality of life and long-term safety in the vast majority of patients.

If you have palpitation complaints, especially if they are accompanied by dizziness or loss of consciousness, or if you have a family history of sudden cardiac death, consulting an electrophysiology specialist is the most important step you should take.

This content is intended for general informational purposes only. Diagnostic and treatment decisions must be individually evaluated by a specialist cardiologist.

Frequently Asked Questions About Ventricular Tachycardia

Ventricular tachycardia is among the rapid rhythm disorders originating from the lower chambers of the heart and is a condition that always requires careful evaluation. However, not all VT carries the same level of risk. While idiopathic VT types seen in patients with structurally normal hearts may have a more favorable course, VTs developing on the background of a previous heart attack, heart failure, or cardiomyopathy can lead to more serious consequences. Therefore, it is important for every patient diagnosed with VT to be evaluated in detail regarding underlying causes.

The most common symptom of VT is a sudden onset of rapid palpitations. In addition, dizziness, shortness of breath, chest tightness, fatigue, sweating, and a feeling of fainting may occur. While loss of consciousness may develop in some patients, certain VT attacks may only be felt as brief palpitations. Especially if palpitations are accompanied by fainting, severe shortness of breath, or chest pain, medical help should be sought without wasting time.

Catheter ablation is an interventional method that enables the treatment of the electrical focus or circuit causing ventricular tachycardia by locating it using special mapping systems. High success rates can be achieved, especially in idiopathic VT types. In patients with structural heart disease, ablation can help reduce VT attacks and ICD shocks. The treatment plan is determined by taking into account the type of VT, the patient's heart function, and their general health status.

No. The decision for an ICD (Implantable Cardioverter Defibrillator) is evaluated individually for each patient. An ICD can be a life-saving treatment option, particularly for patients at high risk of sudden cardiac death, those experiencing sustained VT, or those with significant impairment in heart function. However, medication or catheter ablation may be sufficient for certain types of VT. Therefore, the necessity of an ICD must be determined following a comprehensive cardiological evaluation.

All Electrophysiology and Arrhythmia Treatments

Book an Appointment!

TR|EN